Retraction: Human Phosphatidylethanolamine-Binding Protein 4 Promoted the Radioresistance of Human Rectal Cancer by Activating Akt in an ROS-Dependent Way

The authors explained that they outsourced experiments reported in this article to four external companies. The involvement of external companies was not declared in the article. The authors were unable to provide an explanation for the concerns raised and do not have access to the full raw data underlying any figures in this article. In light of these concerns, the PLOS ONE Editors retract this article. JQ, GY, AL, DW, LD did not respond. ZS could not be reached.

[1]  L. Ding,et al.  Human Phosphatidylethanolamine-Binding Protein 4 Promoted the Radioresistance of Human Rectal Cancer by Activating Akt in an ROS-Dependent Way , 2014, PloS one.

[2]  Lewei Wang,et al.  hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy , 2013, International Journal of Colorectal Disease.

[3]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[4]  I. Afanas’ev.  Reactive oxygen species signaling in cancer: comparison with aging. , 2011, Aging and disease.

[5]  Nan Li,et al.  Human Phosphatidylethanolamine-binding Protein 4 Promotes Transactivation of Estrogen Receptor α (ERα) in Human Cancer Cells by Inhibiting Proteasome-dependent ERα Degradation via Association with Src* , 2010, The Journal of Biological Chemistry.

[6]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[7]  P. Lukas,et al.  Postoperative Morbidity Following Chemoradiation for Locally Advanced Low Rectal Cancer , 2009, Journal of Gastrointestinal Surgery.

[8]  K Kian Ang,et al.  The role of apoptosis in radiation oncology , 2009, International journal of radiation biology.

[9]  K. Akashi,et al.  Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival , 2008, International journal of cancer.

[10]  Nan Li,et al.  hPEBP4 Resists TRAIL-induced Apoptosis of Human Prostate Cancer Cells by Activating Akt and Deactivating ERK1/2 Pathways* , 2007, Journal of Biological Chemistry.

[11]  M. Pollycove.  Radiobiological Basis of Low-Dose Irradiation in Prevention and Therapy of Cancer , 2007, Dose-response : a publication of International Hormesis Society.

[12]  Jeffrey S. Morris,et al.  Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. , 2006, International journal of radiation oncology, biology, physics.

[13]  Nan Li,et al.  Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways. , 2006, International journal of molecular medicine.

[14]  S. Fulda,et al.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.

[15]  L. Påhlman,et al.  Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Y. Takenaka,et al.  Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. , 2005, Cancer research.

[17]  B. Liu,et al.  A Novel Human Phosphatidylethanolamine-binding Protein Resists Tumor Necrosis Factor α-induced Apoptosis by Inhibiting Mitogen-activated Protein Kinase Pathway Activation and Phosphatidylethanolamine Externalization* , 2004, Journal of Biological Chemistry.

[18]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[19]  T. Okumura,et al.  Serine/Threonine Kinase AKT Is Frequently Activated in Human Bile Duct Cancer and Is Associated with Increased Radioresistance , 2004, Cancer Research.

[20]  T. Russo,et al.  Protein Kinase B Activation by Reactive Oxygen Species Is Independent of Tyrosine Kinase Receptor Phosphorylation and Requires Src Activity* , 2003, Journal of Biological Chemistry.

[21]  C. Rödel,et al.  Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. , 2003, International journal of radiation oncology, biology, physics.

[22]  R. Gaynor,et al.  IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. , 2003, Molecular biology of the cell.

[23]  P. Pandolfi,et al.  Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage , 2002, Molecular and Cellular Biology.

[24]  R. Schmidt-Ullrich,et al.  Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. , 2001, Cancer research.

[25]  G. Zauli,et al.  Involvement of the pathway phosphatidylinositol-3-kinase/AKT-1 in the establishment of the survival response to ionizing radiation. , 2001, Cellular signalling.

[26]  N. Holbrook,et al.  Epidermal Growth Factor Receptor-dependent Akt Activation by Oxidative Stress Enhances Cell Survival* , 2000, The Journal of Biological Chemistry.

[27]  E. Kandel,et al.  Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria , 1999, Molecular and Cellular Biology.

[28]  K. Rosenzweig,et al.  Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  S. Powell,et al.  DNA damage and repair following treatment with ionizing radiation. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Z. Xiang,et al.  Promotion of cellular migration and apoptosis resistance by a mouse eye-specific phosphatidylethanolamine-binding protein. , 2007, International journal of molecular medicine.

[31]  A. Balmain,et al.  Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition. , 2006, Cancer research.

[32]  M. Ohmichi,et al.  Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines. , 2004, Endocrinology.

[33]  J. Ward,et al.  Biochemistry of DNA lesions. , 1985, Radiation research. Supplement.